CEL-SCI Newsroom

Express News | CEL-SCI Corp: On November 13, Patricia B Prichep Has Assumed the Duties of Chief Financial and Operations Officer

ReutersNov 15 16:33 ET

CEL-SCI, FDA Agree on Patient Selection Approach for Multikine Study

TipRanksNov 7 09:25 ET

U.S. FDA and CEL-SCI Agree on Use of PD-L1 Biomarker to Select Head and Neck Cancer Patients for Marketing Registration Study to Commence Q1 2025

BusinesswireNov 7 08:15 ET

CEL-SCI Files to Sell 1M Shares of Common Stock for Holders

TipRanksOct 25 17:20 ET

CEL-SCI Announces The Potential Impact On The Clinical Development Of Its Immunotherapy Multikine Resulting From A Recent U.S. FDA Oncologic Drugs Advisory Committee Meeting; Multikine Has Shown Survival Benefit And Favorable Safety Profile In A...

BenzingaOct 22 09:26 ET

CEL-SCI Announces Potential Impact on Multikine Following FDA ODAC Meeting

TipRanksOct 22 09:25 ET

FDA's Oncologic Drugs Advisory Committee Decision on Checkpoint Inhibitors Substantiates Potential of CEL-SCI's Multikine to Address Major Treatment Gap for PD-L1 Negative Cancer Patients

BusinesswireOct 22 09:15 ET

CEL-SCI Selects Ergomed as CRO as It Gears Up for Confirmatory FDA Registration Study of Multikine in Head and Neck Cancer

BusinesswireOct 1 06:00 ET

CEL-SCI's Multikine Increased 5-Year Survival Rate to 82.6% in Locally Advanced Resectable Head & Neck Cancer Patients Who Were Deemed to Be in the Treatment Group for Surgery and Radiation

BusinesswireSep 16 07:30 ET

CEL-SCI to Present New Data for Multikine Head & Neck Cancer Immunotherapy at the European Society for Medical Oncology 2024 Congress

BusinesswireSep 10 09:32 ET

The UK's Medicines & Healthcare Products Regulatory Agency Grants CEL-SCI a Pediatric Waiver, Bringing Multikine One Step Closer to Future Marketing Clearance

BusinesswireSep 4 09:00 ET

Express News | CEL-SCI Q3 2024 Adj EPS $(0.14) Misses $(0.11) Estimate

BenzingaAug 15 08:04 ET

Express News | CEL-SCI Corporation Reports Third Quarter Fiscal 2024 Financial Results

ReutersAug 15 08:00 ET

CEL-SCI 3Q Loss/Shr 14c >CVM

Dow JonesAug 15 08:00 ET

Cel-Sci: Fiscal Q3 Earnings Snapshot

Yahoo FinanceAug 15 05:09 ET

CEL-SCI | 10-Q: Q3 2024 Earnings Report

SECAug 14 16:32 ET · Announcements

Express News | CEL-SCI Announces Closing of $10.8 Million Offering

ReutersJul 29 16:05 ET

Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session

BenzingaJul 26 13:25 ET

Express News | CEL-SCI Shares Resume Trade

BenzingaJul 26 12:15 ET

Express News | CEL-SCI Shares Halted On Circuit Breaker To The Downside, Stock Now Up 21.9%

BenzingaJul 26 11:59 ET